Takeda Pharmaceutical Co ADR (TAK): A Technical Analysis
Takeda Pharmaceutical Co ADR (NYSE: TAK) has a higher price-to-earnings ratio of 32.98x compared to its average ratio. TAK has 36-month beta value of 0.60.
Takeda Pharmaceutical Co ADR (NYSE: TAK) has a higher price-to-earnings ratio of 32.98x compared to its average ratio. TAK has 36-month beta value of 0.60.
Takeda Pharmaceutical Co ADR (NYSE: TAK) has a price-to-earnings ratio that is above its average at 33.46x. The stock has a 36-month beta value of
The stock price of Takeda Pharmaceutical Co ADR (NYSE: TAK) has surged by 0.38 when compared to previous closing price of 13.18, but the company
Takeda Pharmaceutical Co ADR (NYSE: TAK)’s stock price has plunge by 0.37relation to previous closing price of 13.62. Seeking Alpha reported 2024-03-25 that M&A activity
In the past week, TAK stock has gone down by -4.24%, with a monthly decline of -6.94% and a quarterly plunge of -5.05%. The volatility
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.